This MIT spinout wants to spool hair-thin fibers into patients’ brains
NeuroBionics, an MIT spinout, aims to enhance the lives of millions with neurological conditions through innovative solutions, backed by investor Steve Jurvetson.
MAIN POINTS
- NeuroBionics is an MIT spinout company focused on neurological conditions.
- The company targets conditions like depression, epilepsy, and Parkinson's disease.
- Steve Jurvetson, a renowned investor, supports NeuroBionics through Future Ventures.
- The company embodies a spirit of daring essential for startup success.
TAKEAWAYS
- NeuroBionics could significantly impact the treatment of neurological disorders.
- The company's innovative approach is rooted in academic research and expertise.
- Support from high-profile investors boosts NeuroBionics' credibility and potential.
- A bold and daring mindset is crucial for launching successful startups.